[{"StockholdersEquityConverted_0_FY_USD":632795000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":85342000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":648063000.0,"EarningsPerShareDiluted_4_FY_USD":6.71,"CommonStockSharesOutstanding_0_FY_shares":85449000.0,"StockholdersEquity_0_FY_USD":632088000.0,"NetIncomeLossConverted_4_FY_USD":582131000.0,"RevenuesConverted_4_FY_USD":2706655000.0,"Assets_0_FY_USD":2294561000.0,"CommonStockSharesConverted_0_FY_shares":106457000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":86722000.0,"EarningsPerShareBasic_4_FY_USD":6.82,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20210212"}]